Stocks and Investing Stocks and Investing
Fri, April 17, 2020
Thu, April 16, 2020

Chris Howerton Initiated (ACAD) at Strong Buy and Held Target at $60 on, Apr 16th, 2020


Published on 2024-10-27 03:16:14 - WOPRAI, Chris Howerton
  Print publication without navigation


Chris Howerton of Jefferies, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy and Held Target at $60 on, Apr 16th, 2020.

Chris has made no other calls on ACAD in the last 4 months.



There are 4 other peers that have a rating on ACAD. Out of the 4 peers that are also analyzing ACAD, 0 agree with Chris's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Chris


  • Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $72 on, Tuesday, March 31st, 2020
  • Neena Bitritto-Garg of "Citigroup" Initiated at Strong Buy and Held Target at $69 on, Friday, March 6th, 2020
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $75 on, Thursday, February 27th, 2020
  • Yatin Suneja of "Guggenheim" Initiated at Strong Buy and Held Target at $60 on, Monday, December 16th, 2019
Contributing Sources